The Potential Effectiveness of Moclobemide, the New Monoamine Oxidase Inhibitor, in the Prophylaxis of Migraine

@article{Claman1993ThePE,
  title={The Potential Effectiveness of Moclobemide, the New Monoamine Oxidase Inhibitor, in the Prophylaxis of Migraine},
  author={J. Claman},
  journal={Headache: The Journal of Head and Face Pain},
  year={1993},
  volume={33}
}
  • J. Claman
  • Published 1993
  • Medicine
  • Headache: The Journal of Head and Face Pain
Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle
Over more than 60 years, monoamine oxidase (MAO) inhibitors are available for therapy of central nervous diseases. Although they have shown to be efficacious specifically in the treatment of majorExpand
Moclobemide: therapeutic use and clinical studies.
  • U. Bonnet
  • Psychology, Medicine
  • CNS drug reviews
  • 2003
Moclobemide is a reversible inhibitor of monoamine-oxidase-A (RIMA) and has been extensively evaluated in the treatment of a wide spectrum of depressive disorders and less extensively studied inExpand